Xilio Therapeutics, Inc.
XLO
$8.46
-$0.05-0.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.54% | -14.63% | 36.46% | 61.10% | -9.74% |
| Total Receivables | -71.43% | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -11.65% | 30.48% | 1.79% | -56.97% | 141.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.87% | 0.30% | 32.74% | 54.73% | -4.86% |
|
|
|||||
| Total Current Assets | 16.87% | 0.30% | 32.74% | 54.73% | -4.86% |
| Net Property, Plant & Equipment | 0.60% | -6.01% | -4.87% | -3.65% | -5.38% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.33% | 0.39% | 0.34% | 0.34% | 0.39% |
| Total Assets | 15.70% | -0.09% | 29.02% | 45.92% | -4.80% |
|
|
|||||
| Total Accounts Payable | 37.74% | -43.86% | 80.09% | -11.62% | 164.81% |
| Total Accrued Expenses | 31.13% | 59.26% | 44.76% | -61.10% | 1.92% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.07% | 3.09% | 3.10% | 3.20% | 3.13% |
| Total Finance Division Other Current Liabilities | -8.72% | 3.71% | 5.03% | 197.77% | -48.22% |
| Total Other Current Liabilities | -8.72% | 3.71% | 5.03% | 197.77% | -48.22% |
| Total Current Liabilities | -0.23% | 5.90% | 11.80% | 74.74% | -28.30% |
|
|
|||||
| Total Current Liabilities | -0.23% | 5.90% | 11.80% | 74.74% | -28.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.86% | -5.43% | -5.06% | -4.54% | -4.25% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -27.57% | 18.23% | 73.41% | 101.13% | 129.34% |
| Total Liabilities | -15.78% | 11.87% | 36.26% | 73.94% | -0.39% |
|
|
|||||
| Common Stock & APIC | 7.84% | 0.27% | 3.00% | 1.59% | 2.48% |
| Retained Earnings | 2.41% | -3.94% | -3.99% | -3.46% | -3.53% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 535.74% | -214.51% | -33.93% | -39.20% | -16.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 535.74% | -214.51% | -33.93% | -39.20% | -16.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 535.74% | -214.51% | -33.93% | -39.20% | -16.10% |
|
|
|||||